IL10 and inflammatory bowel disease: Flannigan et al. [130] demonstrated that hyperhomocysteinemia exacerbated colitis what was accompanied by decreased colonic H2S synthesis cross-regulated by IL-10 production in colonic tissue suggesting that the IL-10/H2S signaling pathway could be promising target in therapy of inflammatory bowel disease.